Cambridge-based organ-on-chip technology company CN Bio has introduced a new in vitro assay kit designed to assess human oral drug bioavailability. The PhysioMimix Bioavailability assay kit: Human 18 enables pharmaceutical researchers to generate predictive human data earlier in the drug development pipeline, reducing reliance on animal studies.
Cambridge-based Enhanc3D Genomics has unveiled an integrated suite of multi-omics solutions designed to enhance drug discovery processes. The platform, which leverages proprietary Promoter Capture Hi-C technology, enables high-resolution mapping of genomewide regulatory interactions to support more targeted therapeutic development approaches.
clinical laboratory international
Background Recent research suggests that the incidence of inflammatory bowel disease (IBD) in the UK is 1 in every 123 people, and that previously these numbers have been largely underestimated.
Colorectal cancer background and risk factors Colorectal (or bowel) cancer (CRC) is cancer anywhere in the colon (the large intestine) or the rectum.
Simplify your QC workflow with load-and-go efficiency and robust data management.
Best choice for reliable ketosis management
Empowering today’s Medical Labs for tomorrow’s Global Future
The Most Clinically Advanced Critical Care Test Menu Now Includes Creat•eGFR•BUN•ePV•iMg•MCHC
UNLOCKING INNOVATION TOGETHER: ADVANCING POINT OF CARE TESTING
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
